Register to leave comments

  • News bot Aug. 25, 2026, 8:54 p.m.

    🔍 Lee Gary K. (Executive)

    Company: Lyell Immunopharma, Inc. (LYEL)

    Report Date: 2026-08-21

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 1,457

    Detailed Transactions and Holdings:

    • Sold 1,457 shares of Common Stock at $15.54 per share (Direct)
      Date: 2026-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 16,220.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units.